Legionella Testing Market Share, Trends & Forecast by 2034

Legionella Testing Market Outlook from 2024 to 2034

The legionella testing market is expected to be worth US$ 355.1 million in 2024. Diseases caused by Legionella require intensive care and hospitalization as it is considered one of the public health concerns.

The need for legionella testing is projected to rise at a promising CAGR of 9.9% through 2034. The industry is projected to surpass US$ 910 million by 2034. The rise in prevalence of Legionella-related disorders and the surge in awareness about their preventive management is anticipated to drive growth of the market.

Attributes	Details
Legionella Testing Market Value for 2024	US$ 355.1 million
Legionella Testing Market Value for 2034	US$ 910 million
Legionella Testing Market Forecast CAGR for 2024 to 2034	9.9%

Don't pay for what you don't need

Customize your report by selecting specific countries or regions and save 30%!

Key Highlights of the Legionella Testing Industry

The legionella testing industry has validated technological advancements, certainly leading to the development of more authentic and efficient testing methods.
Boom in the availability of rapid testing kits for legionella, thus, offering on-site testing capabilities with quick results.
Symbolic increase in demand for Legionella testing services can be seen leading to growth in awareness of Legionnaires' disease and its probable impact on public health.
The Legionella testing market has accomplished significant growth globally, driven by rise in awareness of regulatory requirements and technological advancements.

Historical Performance and Future Growth of the Legionella Testing Market

Historical CAGR	12.4%
Forecast CAGR	9.9%

The historical CAGR of the Legionella testing market was 12.4%, indicating an impressive rate over the past few years. The forecast CAGR is expected to be 9.9%, indicating a steady decrease in the growth rate through 2034.

The business tests required for Legionella are focusing more on education and training as the awareness of the disease spreads.
Environmental evaluations, risk management advice, and remediation services are some of the services provided by the Legionella testing sector in addition to standard water testing.

The forecast CAGR of 9.9% indicates a decrease in the growth rate of the market in comparison to the historical CAGR in the future. The fall in CAGR can be attributed to several factors, including

Modifications in customer priorities or preferences about Legionella risk control techniques may impact the demand for testing services. For example, the demand certainly increases more slowly when certain clients prioritize investments in other areas of facility management or embrace other risk mitigation strategies.
Unpredicted occurrences, like natural catastrophes, international health emergencies, or geopolitical unrest, might alter market dynamics and impact the market growth trajectory.

Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Key Threats Hampering the Legionella Testing Market

Certain facilities may disregard regulatory standards because they lack the necessary resources, oversight, or knowledge of the rules, resulting in gaps required for testing and possible epidemics.
Due to the rise in financial limitations, some companies might prioritize other expenses over Legionella testing, leaving them vulnerable to outbreaks and legal repercussions.
The complexity of the testing process might be a barrier, resulting in poor or ineffective testing techniques for certain facilities, especially those with little technical experience or resources

Country-wise Insights

The table analyses the top five countries ranked by revenue, with South Korea holding the top position.

Due to government initiatives and technological advancements, South Korea is considered a prominent market. Stringent regulations and proactive measures to improve public health have spurred widespread adoption of Legionella testing in various facilities.

South Korea is a hub for technological innovation, which has led to the development of advanced testing methods and solutions. It is positioning it itself to be a leader in Legionella risk management.

The Forecast CAGRs from 2024 to 2034

Countries	CAGR
United States	10.1%
United Kingdom	11.1%
China	10.5%
Japan	11.4%
South Korea	12%

Stringent Regulatory Requirements Impresses the United States Market

The industry in the United States is heavily utilized due to stringent regulatory requirements imposed by federal and state agencies. Regulations mandate that Legionella testing be done in various facilities, such as healthcare facilities, hotels, and industrial sites, to ensure public health and safety.

High Incidence of Legionnaires Disease Drives the United Kingdom Market

Due to the relatively high incidence of Legionnaires disease, the industry is heavily utilized in the United Kingdom. The surge in awareness and proactive testing measures are taken to prevent future outbreaks in the country.

Rapid Urbanization and Industrialization Grabs Attention towards the China Market

Large-scale infrastructure projects, industrial facilities, and high-rise structures are expanding due to the growth in industrialization and urbanization of the country.

The primary purpose is to reduce the possibility of Legionella contamination in such environments, where dense populations and intricate water systems encourage bacterial growth.

Aging Infrastructure and Public Health Concerns Booms Market Growth in Japan

The aging infrastructure and burgeoning geriatric population in Japan have raised worries over public health and safety.

To ensure public health and safety, the industry widely mitigates the danger of Legionella contamination in public water systems, healthcare facilities, and older buildings.

Government Initiatives and Technological Advancements Boost South Korea Market

Government initiatives to improve public health and safety have prompted the adoption of Legionella testing measures.

The focus on technological advancements and innovation has led to the development of advanced testing methods and solutions, thus driving growth in the industry.

Category-wise Insights

The below section shows the leading segment. Based on type, the urine antigen testing (UAT) segment is registered to expand at 9.7% CAGR by 2034. Based on end-user, the clinical laboratories segment is registered to rise at 9.5% CAGR by 2034.

UAT provides quick, non-invasive results without requiring invasive procedures or specialist equipment for rapid detecteion of Legionella antigens in urine samples.

The rise in demand for diagnostic services is driven by factors such as population growth, aging demographics, and the rising prevalence of chronic diseases.

Category	CAGR from 2024 to 2034
Urine Antigen Testing (UAT)	9.7%
Clinical Laboratories	9.5%

Urine Antigen Testing (UAT) Segment to Hold a Significant Share in the Market

The urine antigen testing (UAT) segment is projected to expand at a CAGR of 9.7% by 2034, driven by its effectiveness and convenience in diagnosing ligionnaires disease.

UAT is becoming more popular as it offers rapid results and high sensitivity in detecting Legionella antigens in urine samples, where adoption is increasing, particularly in clinical settings and timely diagnosis is crucial for patient management.

Clinical Laboratories Segment to Hold a Dominant Share in the Market

Based on end-use, the clinical laboratories market expanded at 9.5% CAGR. There is a boost in demand for clinical laboratories diagnostic services, inclusive of Legionella antigen urine testing.

Clinical laboratories play a critical role in healthcare delivery by offering precise and dependable diagnostic tests, improving patient outcomes, and managing diseases.

Growth in the market is expected as urine antigen testing services are in constant demand from clinical laboratories due to the surge in frequency of Ligionnaires' disease.

Competitive Landscape

Innovative entrepreneurs have used technological breakthroughs to challenge existing players of traditional testing methods in the highly competitive market sector inside the startup ecosystem.

The firms are introducing new testing solutions, like IoT-enabled monitoring devices, AI-powered analytics platforms, and quick testing kits. By providing affordable, user-friendly, and scalable solutions, they have challenged established players and gained traction with industrial sites, healthcare facilities, and other end customers.

Startups prioritizing agility, innovation, and customer-centricity are changing the market and raising competition, certainly leading to better risk management techniques and public health results.

Key developments in the Legionella Testing industry

In May 2022, ChemREADY, launched a novel line of Legionella testing services and products for combating water-borne infections in building water systems. The move underscored the commitment to enhance public health and safety through innovative solutions.
In March 2022, IDEXX announced a significant milestone with its Legiolert test, designed to rapidly detect Legionella pneumophila. ASTM International officially recognized the test as 'ASTM D8429-21: Standard Test Method for Legionella pneumophila in Water Samples Using Legiolert'.

Key Coverage in the Legionella Testing Industry Report

Adjacent Study on Legionella Testing Market
Asia Pacific Legionella Testing Market
Legionella Testing Market Size, Current Insights, and Demographic Trends
Demand for Legionella Testing Market
Key Strategies in Global Legionella Testing Market

Report Scope

Attributes	Details
Estimated Market Size in 2024	US$ 355.1 million
Projected Market Valuation in 2034	US$ 910 million
Value-based CAGR 2024 to 2034	9.9%
Forecast Period	2024 to 2034
Historical Data Available for	2019 to 2023
Market Analysis	Value in US$ million
Key Regions Covered	North America Latin America Western Europe Eastern Europe South Asia and Pacific East Asia The Middle East and Africa
Key Market Segments Covered	Type End User Region
Key Countries Profiled	The United States Canada Brazil Mexico Germany The United Kingdom France Spain Italy Russia Poland Czech Republic Romania India Bangladesh Australia New Zealand China Japan South Korea GCC countries South Africa Israel
Key Companies Profiled	Quidel Corporation Abbott (Alere) Merck KGaA Bio-Rad Laboratories Inc. Thermo Fisher Scientific Inc. Pro-lab Diagnostics Inc. bioMerieux IDEXX Corporation Eurofins Scientific Beckman Coulter Inc.

Key Segments

By Type:

Culture Media
Urine Antigen Testing (UAT)
Polymerase Chain Reaction (PCR)
Serology
Direct Fluorescent Antibody (DFA) Test

By End User:

Hospitals & Clinics
Clinical Laboratories
Others

By Region:

North America
Latin America
Western Europe
Eastern Europe
South Asia and Pacific
East Asia
Middle East and Africa

Frequently Asked Questions

What is the expected worth of the Legionella testing market in 2024?

As of 2024, the market for Legionella testing is expected to be valued at US$ 355.1 million.

What is the market potential for Legionella testing?

The Legionella testing market is projected to expand at a CAGR of 9.9 % between 2024 and 2034.

Which type of segment dominates the Legionella testing market?

The urine antigen testing (UAT) segment is projected to dominate the industry.

What is the anticipated market value for Legionella testing in 2034?

By 2034, the market value of Legionella testing is expected to reach US$ 910 million.

Which country is likely to dominate the Legionella testing market?

South Korea is likely the top-performing market, with a CAGR of 12%.

Table of Content

1. Executive Summary
    1.1. Global Market Outlook
    1.2. Demand-side Trends
    1.3. Supply-side Trends
    1.4. Technology Roadmap Analysis
    1.5. Analysis and Recommendations
2. Market Overview
    2.1. Market Coverage / Taxonomy
    2.2. Market Definition / Scope / Limitations
3. Market Background
    3.1. Market Dynamics
        3.1.1. Drivers
        3.1.2. Restraints
        3.1.3. Opportunity
        3.1.4. Trends
    3.2. Scenario Forecast
        3.2.1. Demand in Optimistic Scenario
        3.2.2. Demand in Likely Scenario
        3.2.3. Demand in Conservative Scenario
    3.3. Opportunity Map Analysis
    3.4. Investment Feasibility Matrix
    3.5. PESTLE and Porter’s Analysis
    3.6. Regulatory Landscape
        3.6.1. By Key Regions
        3.6.2. By Key Countries
    3.7. Regional Parent Market Outlook
4. Global Market Analysis 2019 to 2023 and Forecast, 2024 to 2034
    4.1. Historical Market Size Value (US$ Million) Analysis, 2019 to 2023
    4.2. Current and Future Market Size Value (US$ Million) Projections, 2024 to 2034
        4.2.1. Y-o-Y Growth Trend Analysis
        4.2.2. Absolute $ Opportunity Analysis
5. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Type
    5.1. Introduction / Key Findings
    5.2. Historical Market Size Value (US$ Million) Analysis By Type, 2019 to 2023
    5.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Type, 2024 to 2034
        5.3.1. Culture Media
        5.3.2. Urine Antigen Testing (UAT)
        5.3.3. Polymerase Chain Reaction (PCR)
        5.3.4. Serology
        5.3.5. Direct Fluorescent Antibody (DFA) Test
    5.4. Y-o-Y Growth Trend Analysis By Type, 2019 to 2023
    5.5. Absolute $ Opportunity Analysis By Type, 2024 to 2034
6. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By End-User
    6.1. Introduction / Key Findings
    6.2. Historical Market Size Value (US$ Million) Analysis By End-User, 2019 to 2023
    6.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By End-User, 2024 to 2034
        6.3.1. Hospitals & Clinics
        6.3.2. Clinical Laboratories
        6.3.3. Others
    6.4. Y-o-Y Growth Trend Analysis By End-User, 2019 to 2023
    6.5. Absolute $ Opportunity Analysis By End-User, 2024 to 2034
7. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Region
    7.1. Introduction
    7.2. Historical Market Size Value (US$ Million) Analysis By Region, 2019 to 2023
    7.3. Current Market Size Value (US$ Million) Analysis and Forecast By Region, 2024 to 2034
        7.3.1. North America
        7.3.2. Latin America
        7.3.3. Western Europe
        7.3.4. Eastern Europe
        7.3.5. South Asia and Pacific
        7.3.6. East Asia
        7.3.7. Middle East and Africa
    7.4. Market Attractiveness Analysis By Region
8. North America Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country
    8.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2019 to 2023
    8.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2024 to 2034
        8.2.1. By Country
            8.2.1.1. USA
            8.2.1.2. Canada
        8.2.2. By Type
        8.2.3. By End-User
    8.3. Market Attractiveness Analysis
        8.3.1. By Country
        8.3.2. By Type
        8.3.3. By End-User
    8.4. Key Takeaways
9. Latin America Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country
    9.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2019 to 2023
    9.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2024 to 2034
        9.2.1. By Country
            9.2.1.1. Brazil
            9.2.1.2. Mexico
            9.2.1.3. Rest of Latin America
        9.2.2. By Type
        9.2.3. By End-User
    9.3. Market Attractiveness Analysis
        9.3.1. By Country
        9.3.2. By Type
        9.3.3. By End-User
    9.4. Key Takeaways
10. Western Europe Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country
    10.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2019 to 2023
    10.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2024 to 2034
        10.2.1. By Country
            10.2.1.1. Germany
            10.2.1.2. UK
            10.2.1.3. France
            10.2.1.4. Spain
            10.2.1.5. Italy
            10.2.1.6. Rest of Western Europe
        10.2.2. By Type
        10.2.3. By End-User
    10.3. Market Attractiveness Analysis
        10.3.1. By Country
        10.3.2. By Type
        10.3.3. By End-User
    10.4. Key Takeaways
11. Eastern Europe Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country
    11.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2019 to 2023
    11.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2024 to 2034
        11.2.1. By Country
            11.2.1.1. Poland
            11.2.1.2. Russia
            11.2.1.3. Czech Republic
            11.2.1.4. Romania
            11.2.1.5. Rest of Eastern Europe
        11.2.2. By Type
        11.2.3. By End-User
    11.3. Market Attractiveness Analysis
        11.3.1. By Country
        11.3.2. By Type
        11.3.3. By End-User
    11.4. Key Takeaways
12. South Asia and Pacific Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country
    12.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2019 to 2023
    12.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2024 to 2034
        12.2.1. By Country
            12.2.1.1. India
            12.2.1.2. Bangladesh
            12.2.1.3. Australia
            12.2.1.4. New Zealand
            12.2.1.5. Rest of South Asia and Pacific
        12.2.2. By Type
        12.2.3. By End-User
    12.3. Market Attractiveness Analysis
        12.3.1. By Country
        12.3.2. By Type
        12.3.3. By End-User
    12.4. Key Takeaways
13. East Asia Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country
    13.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2019 to 2023
    13.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2024 to 2034
        13.2.1. By Country
            13.2.1.1. China
            13.2.1.2. Japan
            13.2.1.3. South Korea
        13.2.2. By Type
        13.2.3. By End-User
    13.3. Market Attractiveness Analysis
        13.3.1. By Country
        13.3.2. By Type
        13.3.3. By End-User
    13.4. Key Takeaways
14. Middle East and Africa Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country
    14.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2019 to 2023
    14.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2024 to 2034
        14.2.1. By Country
            14.2.1.1. GCC Countries
            14.2.1.2. South Africa
            14.2.1.3. Israel
            14.2.1.4. Rest of MEA
        14.2.2. By Type
        14.2.3. By End-User
    14.3. Market Attractiveness Analysis
        14.3.1. By Country
        14.3.2. By Type
        14.3.3. By End-User
    14.4. Key Takeaways
15. Key Countries Market Analysis
    15.1. USA
        15.1.1. Market Share Analysis, 2023
            15.1.1.1. By Type
            15.1.1.2. By End-User
    15.2. Canada
        15.2.1. Market Share Analysis, 2023
            15.2.1.1. By Type
            15.2.1.2. By End-User
    15.3. Brazil
        15.3.1. Market Share Analysis, 2023
            15.3.1.1. By Type
            15.3.1.2. By End-User
    15.4. Mexico
        15.4.1. Market Share Analysis, 2023
            15.4.1.1. By Type
            15.4.1.2. By End-User
    15.5. Germany
        15.5.1. Market Share Analysis, 2023
            15.5.1.1. By Type
            15.5.1.2. By End-User
    15.6. UK
        15.6.1. Market Share Analysis, 2023
            15.6.1.1. By Type
            15.6.1.2. By End-User
    15.7. France
        15.7.1. Market Share Analysis, 2023
            15.7.1.1. By Type
            15.7.1.2. By End-User
    15.8. Spain
        15.8.1. Market Share Analysis, 2023
            15.8.1.1. By Type
            15.8.1.2. By End-User
    15.9. Italy
        15.9.1. Market Share Analysis, 2023
            15.9.1.1. By Type
            15.9.1.2. By End-User
    15.10. Poland
        15.10.1. Market Share Analysis, 2023
            15.10.1.1. By Type
            15.10.1.2. By End-User
    15.11. Russia
        15.11.1. Market Share Analysis, 2023
            15.11.1.1. By Type
            15.11.1.2. By End-User
    15.12. Czech Republic
        15.12.1. Market Share Analysis, 2023
            15.12.1.1. By Type
            15.12.1.2. By End-User
    15.13. Romania
        15.13.1. Market Share Analysis, 2023
            15.13.1.1. By Type
            15.13.1.2. By End-User
    15.14. India
        15.14.1. Market Share Analysis, 2023
            15.14.1.1. By Type
            15.14.1.2. By End-User
    15.15. Bangladesh
        15.15.1. Market Share Analysis, 2023
            15.15.1.1. By Type
            15.15.1.2. By End-User
    15.16. Australia
        15.16.1. Market Share Analysis, 2023
            15.16.1.1. By Type
            15.16.1.2. By End-User
    15.17. New Zealand
        15.17.1. Market Share Analysis, 2023
            15.17.1.1. By Type
            15.17.1.2. By End-User
    15.18. China
        15.18.1. Market Share Analysis, 2023
            15.18.1.1. By Type
            15.18.1.2. By End-User
    15.19. Japan
        15.19.1. Market Share Analysis, 2023
            15.19.1.1. By Type
            15.19.1.2. By End-User
    15.20. South Korea
        15.20.1. Market Share Analysis, 2023
            15.20.1.1. By Type
            15.20.1.2. By End-User
    15.21. GCC Countries
        15.21.1. Market Share Analysis, 2023
            15.21.1.1. By Type
            15.21.1.2. By End-User
    15.22. South Africa
        15.22.1. Market Share Analysis, 2023
            15.22.1.1. By Type
            15.22.1.2. By End-User
    15.23. Israel
        15.23.1. Market Share Analysis, 2023
            15.23.1.1. By Type
            15.23.1.2. By End-User
16. Market Structure Analysis
    16.1. Competition Dashboard
    16.2. Competition Benchmarking
    16.3. Market Share Analysis of Top Players
        16.3.1. By Regional
        16.3.2. By Type
        16.3.3. By End-User
17. Competition Analysis
    17.1. Competition Deep Dive
        17.1.1. Quidel Corporation
            17.1.1.1. Overview
            17.1.1.2. Product Portfolio
            17.1.1.3. Profitability by Market Segments
            17.1.1.4. Sales Footprint
            17.1.1.5. Strategy Overview
                17.1.1.5.1. Marketing Strategy
        17.1.2. Abbott (Alere)
            17.1.2.1. Overview
            17.1.2.2. Product Portfolio
            17.1.2.3. Profitability by Market Segments
            17.1.2.4. Sales Footprint
            17.1.2.5. Strategy Overview
                17.1.2.5.1. Marketing Strategy
        17.1.3. Merck KGaA
            17.1.3.1. Overview
            17.1.3.2. Product Portfolio
            17.1.3.3. Profitability by Market Segments
            17.1.3.4. Sales Footprint
            17.1.3.5. Strategy Overview
                17.1.3.5.1. Marketing Strategy
        17.1.4. Bio-Rad Laboratories, Inc.
            17.1.4.1. Overview
            17.1.4.2. Product Portfolio
            17.1.4.3. Profitability by Market Segments
            17.1.4.4. Sales Footprint
            17.1.4.5. Strategy Overview
                17.1.4.5.1. Marketing Strategy
        17.1.5. Thermo Fisher Scientific Inc.
            17.1.5.1. Overview
            17.1.5.2. Product Portfolio
            17.1.5.3. Profitability by Market Segments
            17.1.5.4. Sales Footprint
            17.1.5.5. Strategy Overview
                17.1.5.5.1. Marketing Strategy
        17.1.6. Pro-lab Diagnostics, Inc.
            17.1.6.1. Overview
            17.1.6.2. Product Portfolio
            17.1.6.3. Profitability by Market Segments
            17.1.6.4. Sales Footprint
            17.1.6.5. Strategy Overview
                17.1.6.5.1. Marketing Strategy
        17.1.7. bioMérieux
            17.1.7.1. Overview
            17.1.7.2. Product Portfolio
            17.1.7.3. Profitability by Market Segments
            17.1.7.4. Sales Footprint
            17.1.7.5. Strategy Overview
                17.1.7.5.1. Marketing Strategy
        17.1.8. IDEXX Corporation
            17.1.8.1. Overview
            17.1.8.2. Product Portfolio
            17.1.8.3. Profitability by Market Segments
            17.1.8.4. Sales Footprint
            17.1.8.5. Strategy Overview
                17.1.8.5.1. Marketing Strategy
        17.1.9. Eurofins Scientific
            17.1.9.1. Overview
            17.1.9.2. Product Portfolio
            17.1.9.3. Profitability by Market Segments
            17.1.9.4. Sales Footprint
            17.1.9.5. Strategy Overview
                17.1.9.5.1. Marketing Strategy
        17.1.10. Beckman Coulter, Inc.
            17.1.10.1. Overview
            17.1.10.2. Product Portfolio
            17.1.10.3. Profitability by Market Segments
            17.1.10.4. Sales Footprint
            17.1.10.5. Strategy Overview
                17.1.10.5.1. Marketing Strategy
18. Assumptions & Acronyms Used
19. Research Methodology

Legionella Testing Market

Legionella Testing Market Analysis by Culture Media, Urine Antigen Testing (UAT), and Other Types from 2024 to 2034